Dry mouth is more than a comfort issue. When saliva drops, adults may be more prone to cavities, mouth sores, bad breath, and trouble chewing or swallowing. Medications are a common reason, and the risk can build when several drugs are taken together. Here’s how to spot it and what to discuss with a dentist or clinician.
A multistate E. coli outbreak linked to raw cheddar cheese and raw milk has ended, but the recall is a reminder that unpasteurized dairy can carry serious food-safety risks — especially for young children and other people more likely to get very sick. Here’s what happened, what to check at home, and when symptoms need urgent care.
RSV is still showing up in parts of the United States even as overall respiratory illness remains very low. CDC says the season arrived later than expected in many regions, which is why some communities may still see RSV activity in May. For older adults and others at higher risk, now is still a good time to check vaccine status and watch for warning signs.
The FDA has proposed excluding semaglutide, tirzepatide, and liraglutide from a federal list used by some outsourcing compounders. If finalized, the change could narrow access to some compounded GLP-1 weight-loss products. The proposal does not change the approval status of brand-name obesity medicines. It does raise fresh questions about access, quality, and how compounded versions differ from FDA-approved drugs.
The FDA says thousands of clinical trial results still are not being reported as required, leaving gaps that can make medicines and devices look better understood than they are. For readers, the key takeaway is simple: one study rarely tells the whole story, especially when negative or inconclusive findings never make it into the public record.
CMS has proposed extending its electronic prior-authorization rules to prescription drugs, with comments open through June 15, 2026. If finalized, the change could reduce paperwork and speed some decisions, but prior authorization would still exist and results could vary by plan.
The FDA says B. Braun has recalled two lots of Lactated Ringer’s Injection after particulate matter was found in the solution. The recall mainly affects hospitals, clinics, and other facilities that stocked the affected lots, but patients who recently received this IV fluid may want to check with the treating facility if they have concerns.
FDA’s updated “healthy” claim can help shoppers compare packaged foods, but it is only one clue. Readers still need to check sodium, added sugars, saturated fat, and serving size on the Nutrition Facts panel before treating the label as a health verdict.
CMS has proposed new rules that would push more drug prior authorizations into electronic workflows and set tighter decision timelines for several federally regulated health plans. If finalized, the changes could affect Medicare Advantage, Medicaid, CHIP, and ACA Marketplace plans, but details would still vary by plan and state.
The FDA says a Class I recall covers TRUE METRIX blood glucose monitoring systems because an E-5 error code can mean either very high blood sugar or a strip problem. That mix-up can delay treatment or lead to the wrong response, so users should know the warning signs, confirm what device they have, and check the latest FDA guidance.
CDC’s latest respiratory dashboard shows a quiet late-season national picture: COVID-19 is low, flu is declining, and overall respiratory illness activity is very low. RSV is the main exception, because it started later than expected and may still linger in some regions into May.
CDC recommends a one-time hepatitis B screening for all adults age 18 and older, using three blood tests together. The goal is to find hidden infection early, identify who is immune, and connect people to vaccination or care when needed.
CMS has proposed shorter deadlines and more electronic processing for prescription-drug prior authorizations in several federal health coverage programs. The plan would not end prior authorization, but it could reduce delays and improve transparency around denials and appeals.
The FDA says certain Omnipod 5 pods are part of a Class I recall because a manufacturing defect may let insulin leak inside the pod. The notice says affected users should stop using impacted pods, check lot numbers, and switch to unaffected pods or contact Insulet for replacements.
Measles is climbing again in 2026, and the most useful response for families is simple: know the signs, check vaccination status, and follow local public-health guidance after exposure. The outbreak is active, but it remains preventable with timely vaccination and fast action when symptoms appear.
Worry is common, but anxiety can cross the line when it lasts, feels hard to control, and starts disrupting daily life. Here’s how to spot the difference, what short-term self-care may help, and when to reach out for professional care.
CMS has proposed a new rule that would expand electronic prior authorization to drugs and add faster decision timelines for some plans. The change is not final yet, and the details could still change after public comment closes on June 15, 2026.
The FDA has proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulks list, a move that could affect some compounded GLP-1 products. Patients using compounded versions should not make changes on their own; they should check with the prescriber or pharmacist about supply, cost, and next steps.
Falls remain the leading cause of injury death for adults 65 and older, and recent CDC data show the death rate is still rising. The good news: many falls can be prevented with a mix of eye care, home changes, safer medicine use, and strength-and-balance work.
The FDA has updated when food packages can use the word “healthy.” The claim now better reflects current nutrition guidance, but it is still only a shortcut. Shoppers should keep checking the Nutrition Facts label for serving size, sodium, added sugars, and saturated fat.
The U.S. Preventive Services Task Force says clinicians should screen women of reproductive age, including pregnant and postpartum patients, for intimate partner violence. The same update says evidence is still insufficient to recommend routine screening for caregiver abuse in older or vulnerable adults.
An NIH-funded study suggests a symptom-based approach may help newborns with opioid withdrawal recover sooner and spend less time on medicine. The findings are promising, but the approach was tested in a specific hospital setting and is not yet universal practice.
End of content
End of content
